These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28975809)

  • 1. Cross-reactivity of selected benzofurans with commercial amphetamine and ecstasy immunoassays in urine.
    Gomila I; Moranta C; Quesada L; Pastor Y; Dastis M; Torrents A; Elorza MÁ; Busardò FP; Barceló B
    Bioanalysis; 2017 Nov; 9(22):1771-1785. PubMed ID: 28975809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intoxication caused by new psychostimulants: analytical methods to disclose acute and chronic use of benzofurans and ethylphenidate.
    Barceló B; Gomila I; Rotolo MC; Marchei E; Kyriakou C; Pichini S; Roset C; Elorza MÁ; Busardò FP
    Int J Legal Med; 2017 Nov; 131(6):1543-1553. PubMed ID: 28710651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison and evaluation of DRI methamphetamine, DRI ecstasy, Abuscreen ONLINE amphetamine, and a modified Abuscreen ONLINE amphetamine screening immunoassays for the detection of amphetamine (AMP), methamphetamine (MTH), 3,4-methylenedioxyamphetamine (MDA), and 3,4-methylenedioxymethamphetamine (MDMA) in human urine.
    Stout PR; Klette KL; Wiegand R
    J Anal Toxicol; 2003; 27(5):265-9. PubMed ID: 12908938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzofuran analogues of amphetamine and methamphetamine: studies on the metabolism and toxicological analysis of 5-APB and 5-MAPB in urine and plasma using GC-MS and LC-(HR)-MS(n) techniques.
    Welter J; Kavanagh P; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2015 Feb; 407(5):1371-88. PubMed ID: 25471293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic fate, mass spectral fragmentation, detectability, and differentiation in urine of the benzofuran designer drugs 6-APB and 6-MAPB in comparison to their 5-isomers using GC-MS and LC-(HR)-MS(n) techniques.
    Welter J; Brandt SD; Kavanagh P; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2015 May; 407(12):3457-70. PubMed ID: 25711990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. False positive amphetamines and 3,4-methylenedioxymethamphetamine immunoassays in the presence of metoprolol-two cases reported in clinical toxicology.
    Leclercq M; Soichot M; Delhotal-Landes B; Bourgogne E; Gourlain H; Mégarbane B; Labat L
    J Anal Toxicol; 2020 Mar; 44(2):200-205. PubMed ID: 31384953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiles of urine samples taken from Ecstasy users at Rave parties: analysis by immunoassays, HPLC, and GC-MS.
    Zhao H; Brenneisen R; Scholer A; McNally AJ; ElSohly MA; Murphy TP; Salamone SJ
    J Anal Toxicol; 2001; 25(4):258-69. PubMed ID: 11386639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance characteristics of selected immunoassays for preliminary test of 3,4-methylenedioxymethamphetamine, methamphetamine, and related drugs in urine specimens.
    Hsu J; Liu C; Liu CP; Tsay WI; Li JH; Lin DL; Liu RH
    J Anal Toxicol; 2003 Oct; 27(7):471-8. PubMed ID: 14607002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of amphetamine/methamphetamine and other cross-immunoreactive sympathomimetic amines in urine samples by serial dilution testing.
    Woodworth A; Saunders AN; Koenig JW; Moyer TP; Turk J; Dietzen DJ
    Clin Chem; 2006 Apr; 52(4):743-6. PubMed ID: 16455869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of ephedrine, pseudoephedrine and phenylpropanolamine concentrations in human urine samples and a comparison of the specificity of DRI amphetamines and Abuscreen online (KIMS) amphetamines screening immunoassays.
    Stout PR; Klette KL; Horn CK
    J Forensic Sci; 2004 Jan; 49(1):160-4. PubMed ID: 14979364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. False-positive amphetamine/ecstasy (MDMA/3,4-methylenedioxymethamphetamine) (CEDIA) and ecstasy (MDMA/3,4-methylenedioxymethamphetamine) (DRI) test results with fenofibrate.
    Kaplan YC; Erol A; Karadaş B
    Ther Drug Monit; 2012 Oct; 34(5):493-5. PubMed ID: 22972534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactivity studies and predictive modeling of "Bath Salts" and other amphetamine-type stimulants with amphetamine screening immunoassays.
    Petrie M; Lynch KL; Ekins S; Chang JS; Goetz RJ; Wu AH; Krasowski MD
    Clin Toxicol (Phila); 2013 Feb; 51(2):83-91. PubMed ID: 23387345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. False-Positive Amphetamines in Urine Drug Screens: A 6-Year Review.
    Pope JD; Drummer OH; Schneider HG
    J Anal Toxicol; 2023 Mar; 47(3):263-270. PubMed ID: 36367744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detectability of new psychoactive substances, 'legal highs', in CEDIA, EMIT, and KIMS immunochemical screening assays for drugs of abuse.
    Beck O; Rausberg L; Al-Saffar Y; Villen T; Karlsson L; Hansson T; Helander A
    Drug Test Anal; 2014 May; 6(5):492-9. PubMed ID: 24665024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of five substituted phenethylamine derivatives 5-MAPDB, 5-AEDB, MDMA methylene homolog, 6-Br-MDMA, and 5-APB-NBOMe.
    Liu C; Jia W; Qian Z; Li T; Hua Z
    Drug Test Anal; 2017 Feb; 9(2):199-207. PubMed ID: 26856255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Retrospective Analysis of Urine Drugs of Abuse Immunoassay True Positive Rates at a National Reference Laboratory.
    Johnson-Davis KL; Sadler AJ; Genzen JR
    J Anal Toxicol; 2016 Mar; 40(2):97-107. PubMed ID: 26668238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct injection LC-MS/MS method for identification and quantification of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in urine drug testing.
    Andersson M; Gustavsson E; Stephanson N; Beck O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(1):22-8. PubMed ID: 18088576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of three commercial amphetamine immunoassays for detection of methamphetamine, methylenedioxyamphetamine, methylenedioxymethamphetamine, and methylenedioxyethylamphetamine.
    Ruangyuttikarn W; Moody DE
    J Anal Toxicol; 1988; 12(4):229-33. PubMed ID: 2903272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of six commercial amphetamine and methamphetamine immunoassays for cross-reactivity to phenylpropanolamine and ephedrine in urine.
    D'Nicuola J; Jones R; Levine B; Smith ML
    J Anal Toxicol; 1992; 16(4):211-3. PubMed ID: 1501473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the sensitivity and specificity of six immunoassays for the detection of amphetamines in urine.
    Verstraete AG; Heyden FV
    J Anal Toxicol; 2005; 29(5):359-64. PubMed ID: 16105261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.